🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 107 of 200 · A–Z by INN

  1. lecanemab

    LEQEMBI

    EMA: approved · PMDA: approved

    N06DX04

  2. lecanemab-irmb

    LEQEMBI

    INJECTION FDA: approved

  3. ledipasvir

    HARVONI

    ORAL FDA: approved

  4. ledipasvir acetonate/sofosbuvir

    HARVONI

    PMDA: approved

  5. ledispavir

    HARVONI

    EMA: approved

    J05AX65

  6. lefamulin

    XENLETA

    EMA: approved

    J01XX

  7. lefamulin acetate

    XENLETA

    ORAL FDA: approved

  8. leflunomide

    APO-LEFLUNOMIDE Alphapharm Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved

    L04AK01

  9. lemborexant

    DAYVIGO

    ORAL FDA: approved · PMDA: approved

  10. lenacapavir

    SUNLENCA

    SUBCUTANEOUS FDA: approved · EMA: approved

    J05AX31

  11. lenacapavir sodium

    SUNLENCA

    SUBCUTANEOUS FDA: approved

  12. lenadogene nolparvovec

    LUMEVOQ

    EMA: application withdrawn

    S01

  13. lenalidomide

    LENALIDE Bristol-Myers Squibb Australia Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    L04AX07

  14. lenalidomide hydrate

    REVLIMID PARTIAL CHANGE APPROVAL

    PMDA: approved

  15. leniolisib

    JOENJA

    EMA: unknown

  16. leniolisib phosphate

    JOENJA

    ORAL FDA: approved

  17. lenvatinib

    LENVIMA Eisai Co.,

    EMA: approved · TGA: approved · NMPA: clinical trials

    L01XE29

  18. lenvatinib mesilate

    LENVIMA INITIAL APPROVAL

    PMDA: approved

  19. lenvatinib mesylate

    LENVIMA

    ORAL FDA: approved

  20. lepirudin

    REFLUDAN

    EMA: withdrawn

    B01AE02

  21. lercanidipine

    ZIRCOL 10 Alphapharm Pty Ltd

    TGA: approved

  22. lercanidipine + enalapril

    ZAN-EXTRA 10/20 Viatris Pharmaceuticals Co.,

    TGA: approved

  23. leriglitazone

    NEZGLYAL

    EMA: refused

    A16AX23

  24. lerodalcibep-liga

    LEROCHOL

    INJECTION FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources